Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeutics
about
T-cell receptor gene therapy--ready to go viral?Cross-species gene expression analysis of species specific differences in the preclinical assessment of pharmaceutical compoundsProdrug applications for targeted cancer therapy.Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.Epidermal Growth Factor Receptor Silencing Blunts the Slow Force Response to Myocardial Stretch.Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.Management of Advanced Heart Failure due to Cancer Therapy: the Present Role of Mechanical Circulatory Support and Cardiac Transplantation.Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor RCardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06).Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung.
P2860
Q28081611-A2B53A84-CE00-4371-A246-3E9D84B33ED9Q28538757-A6B6F6F1-6CF3-47C2-BF62-F668E6A2D8C1Q34099780-5474A80B-F9E3-4378-8503-5E1511E55892Q34797559-78538B30-B25D-4134-8980-A7D2E52BE438Q37038711-EC4B4892-D173-428D-B74F-3DC55FD7970CQ37434706-97416A49-866C-4083-BEFE-B32F41E15464Q38987239-09C23C67-0225-4744-91D6-6FB983C7ED65Q41243586-D01EF120-B977-4F70-B0C7-47E96E6A5706Q47107119-1B8CA4B7-E7A4-4072-BE6E-AA53944BE914Q47894494-239C954F-ED68-44B3-BD4C-EFEAB54FD321Q47931199-983B51E1-BE3C-4EC8-9426-5A7B44DD3914
P2860
Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeutics
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Molecular mechanisms of cardio ...... inhibitor cancer therapeutics
@ast
Molecular mechanisms of cardio ...... inhibitor cancer therapeutics
@en
type
label
Molecular mechanisms of cardio ...... inhibitor cancer therapeutics
@ast
Molecular mechanisms of cardio ...... inhibitor cancer therapeutics
@en
prefLabel
Molecular mechanisms of cardio ...... inhibitor cancer therapeutics
@ast
Molecular mechanisms of cardio ...... inhibitor cancer therapeutics
@en
P2860
P921
P356
P1476
Molecular mechanisms of cardio ...... inhibitor cancer therapeutics
@en
P2093
Anne-Sophie Hervent
P2860
P304
12268-12286
P356
10.3390/IJMS131012268
P407
P5008
P577
2012-09-26T00:00:00Z